Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Person

Stéphane Bancel

Tracked across 9 events · 949 articles · First seen May 29, 2025 · Last active Sep 08, 2026

Sentiment
42
Attention
7
Events
9
Relationships
12
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
6 60
Regulatory
Impact: Stéphane Bancel, CEO of Moderna, expressed appreciation for the United States — Food and Drug Administration's engagement and agreement to review the vaccine, highlighting the company's goal to make the flu vaccine available to seniors.
Feb 18, 2026 · 9 articles
7 60
International
Impact: Stéphane Bancel, CEO of Moderna, pledged urgency and scientific rigor in developing a Bundibugyo vaccine.
May 21, 2026 · 627 articles
7 70
Regulatory
Impact: As CEO, Bancel championed the vaccine and highlighted its importance for seniors and the company's future.
Aug 05, 2026 · 105 articles
7 90
Tech
On August 19, 2026, Moderna and Merck announced that their personalized mRNA cancer vaccine, intismeran autogene, combined with Merck's immunotherapy Pembrolizumab, met its primary and secondary endpoints in a Phase 3 trial involving 1,137 patients…
Impact: As CEO of Moderna, Bancel is a key figure in the announcement and the company's strategic direction. The trial success is a personal and professional vindication, and he has stated the vaccine could be approved as soon as 2027.
Aug 19, 2026 · 126 articles
6 60
Tech
Impact: Stéphane Bancel>>>, CEO of Moderna>>>, expressed pride in the expanded collaboration, highlighting Moderna's>>> commitment to rapid response to infectious disease threats.
May 22, 2026 · 36 articles
4 30
Regulatory
Impact: As CEO, Stéphane Bancel announced the approval and highlighted the public health importance, reinforcing leadership.
Aug 27, 2026 · 6 articles
4 0
Regulatory
Impact: Stéphane Bancel, Moderna's CEO, expressed disappointment with the United States — Food and Drug Administration's decision, stating it does not further shared goals of innovation.
Feb 10, 2026 · 6 articles
2 0
Business
Impact: CEO Stéphane Bancel expressed delight at McDonnell's appointment, citing his industry understanding.
Jul 08, 2026 · 6 articles
7 10
Regulatory
Impact: Stéphane Bancel, CEO of Moderna, expressed appreciation for the VRBPAC's review and highlighted the potential of mRNA-1010 to offer a new option for seasonal flu prevention, reinforcing the company's commitment to the vaccine.
Jun 18, 2026 · 28 articles
60 Stéphane Bancel called findings pivotalModerna Merck mRNA...
50 Stéphane Bancel called findings pivotalModerna Merck mRNA...
Dean Y. Li ↔ Stéphane Bancel
Dean Y. Li ↔ Stéphane Bancel
Merck Group ↔ Stéphane Bancel
Merck Group ↔ Stéphane Bancel
Moderna ↔ Stéphane Bancel
Moderna ↔ Stéphane Bancel
United States ↔ Stéphane Bancel
United States ↔ Stéphane Bancel
ERGEN INTELLIGENCE
Track Stéphane Bancel live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.